FDA PATIENT-REPORTED OUTCOME LABELING OF NOVEL THERAPIES (2011-2015)

被引:0
|
作者
Gnanasakthy, A. [1 ]
Mordin, M. [1 ]
Haydysch, E. [1 ]
DeMuro, C. [1 ]
机构
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
关键词
D O I
10.1016/j.jval.2016.03.1950
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP164
引用
收藏
页码:A285 / A286
页数:2
相关论文
共 50 条
  • [1] A Review of Patient-Reported Outcome Labeling in the United States (2011-2015)
    Gnanasakthy, Ari
    Mordin, Margaret
    Evans, Emily
    Doward, Lynda
    DeMuro, Carla
    [J]. VALUE IN HEALTH, 2017, 20 (03) : 420 - 429
  • [2] Variations in patient-reported outcome (PRO) collection and reporting in novel FDA approved anticancer therapies.
    Singhal, Surbhi
    Hall, Evan Thomas
    Gabster, Brooke Peterson
    Dickerson, James
    Schapira, Lidia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Recent trends in the inclusion of patient-reported outcome (PRO) data in approved drugs labeling by FDA and EMEA
    Caron, M.
    Emery, M. P.
    Marquis, P.
    Piault, E.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A54 - A54
  • [4] UPDATE OF TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA
    Caron, M.
    Emery, M. P.
    Marquis, P.
    Piault, E.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A574 - A574
  • [5] OUTCOME ASSESSMENTS OF PRIMARY ENDPOINTS OF NEW DRUGS APPROVED BY THE FDA (2011-2015)
    Gnanasakthy, A.
    DeMuro, C.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A275 - A275
  • [6] PATIENT-REPORTED OUTCOME LABELING FOR GASTROINTESTINAL DRUGS APPROVED IN THE UNITED STATES: 2011-2016
    Zettler, Marjorie E.
    Lim, Joel D.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S999 - S999
  • [7] Patient-Reported Outcome Labeling for Antidiabetic Agents Approved in the United States, 2011-2017
    Zettler, Marjorie E.
    Sandoval, Renato
    [J]. DIABETES, 2018, 67
  • [8] Patient-Reported Outcome Labeling for Cardiovascular Drugs Approved in the United States: 2011-2017
    Zettler, Marjorie E.
    Lieu, Hsiao
    [J]. CIRCULATION, 2018, 138
  • [9] PATIENT-REPORTED OUTCOMES IN LABELING FOR NOVEL ONCOLOGY AGENTS
    Champion, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S107 - S107
  • [10] Patient-reported outcomes to support medical product labeling claims: FDA perspective
    Patrick, Donald L.
    Burke, Laurie B.
    Powers, John H.
    Scott, Jane A.
    Rock, Edwin P.
    Dawisha, Sahar
    O'Neill, Robert
    Kennedy, Dianne L.
    [J]. VALUE IN HEALTH, 2007, 10 : S125 - S137